CPT® Code 81552

1. Indications

The procedure associated with CPT® Code 81552 is indicated for the assessment of uveal melanoma, particularly in the following scenarios:

• Uveal Melanoma Diagnosis The test is performed on patients diagnosed with uveal melanoma to evaluate the genetic profile of the tumor.
• Risk Assessment for Metastasis It is utilized to determine the likelihood of metastasis in patients with uveal melanoma, providing critical information for treatment planning.
• Monitoring Disease Progression The test may be indicated for monitoring changes in gene expression over time, which can inform the current disease status and response to treatment.

2. Procedure

The procedure for CPT® Code 81552 involves several key steps that ensure accurate gene expression profiling:

• Sample Collection The first step involves obtaining a sample from the patient, which can be either a fine needle aspirate of the tumor or a formalin-fixed paraffin-embedded (FFPE) tissue specimen. This sample is crucial as it contains the genetic material necessary for analysis.
• RNA Extraction Once the sample is collected, the next step is to extract the messenger RNA (mRNA) from the tissue. This process involves breaking down the cellular components to isolate the mRNA, which is essential for the subsequent analysis.
• Real-Time RT-PCR The extracted mRNA is then subjected to real-time reverse transcriptase polymerase chain reaction (RT-PCR). This technique amplifies the mRNA, allowing for the quantification of the expression levels of the 15 specific genes being studied.
• Data Analysis After amplification, the data generated from the RT-PCR is analyzed using a predefined algorithm. This algorithm interprets the expression levels of the 12 content genes and 3 housekeeping genes to assess the risk of metastasis.
• Reporting Results Finally, the results are compiled into a report that includes a risk score for metastasis. This score provides valuable information to healthcare providers regarding the patient's prognosis and potential treatment strategies.

3. Post-Procedure

Post-procedure care for patients undergoing the testing associated with CPT® Code 81552 typically involves monitoring for any immediate complications related to the sample collection, especially if a fine needle aspirate was performed. Patients may be advised on follow-up appointments to discuss the results of the gene expression profiling. The risk score generated from the test will guide further management decisions, including potential treatment options and the need for additional monitoring for metastasis. It is essential for healthcare providers to communicate the implications of the test results to the patient and to develop a comprehensive care plan based on the findings.